BioXGEM.
KIDFamMap
Home
Example1
Example2
Statistics
Document
Contact US
Diseases
Inhibitor-Anchor Map
Family Anchors
Kinase-Inhibitor Family
Template
Protein
Surface
Ribbon
Inhibitor
ATP Location
Pocket
ATP
NLP
HAP
CLP
SP
Summary of query kinase
Query kinase
DDR1 (
Q08345
)
Kinase group
TK
Number of conformation types
0
Number of structural templates
99 (
Total 100 inhibitors
)
Select
Template
Comformation
Type
No. of
Templates
Representative
Template
Kinase
Group
Representative
Inhibitor
Inhibitor
Type
No. of
Kinases
No. of
Inhibitors
No. of
Diseases
A
39
2IVUA_ZD6
(RET)
TK
Vandetanib
I
83
291
121
A
2IVUA_ZD6
(RET)
TK
Vandetanib
I
83
291
121
83
291
121
A
1SM2A_STU
(ITK)
TK
staurosporine
I
99
104
128
99
104
128
A
1SNUA_STU
(ITK)
TK
staurosporine
I
99
104
128
99
104
128
A
1U59A_STU
(ZAP70)
TK
staurosporine
I
96
80
114
96
80
114
A
2C0IA_L1G
(HCK)
TK
A-420983
I
61
269
86
61
269
86
A
1XBCA_STU
(SYK)
TK
staurosporine
I
71
72
105
71
72
105
A
1AQ1A_STU
(CDK2)
TK
staurosporine
I
195
76
118
195
76
118
A
1YVJA_4ST
(JAK3)
TK
staurosporine
I
96
90
126
96
90
126
A
2OFUA_1N9
(LCK)
TK
2-aminopyrim...
I
55
215
101
55
215
101
A
1PKDA_UCN
(CDK2)
TK
UCN 02
I
195
67
118
195
67
118
A
2DQ7X_STU
(FYN)
TK
staurosporine
I
91
74
124
91
74
124
A
1QPDA_STU
(LCK)
TK
staurosporine
I
115
76
126
115
76
126
A
2HZ4A_4ST
(ABL1)
TK
staurosporine
I
159
103
156
159
103
156
A
1QPJA_STU
(LCK)
TK
staurosporine
I
115
76
126
115
76
126
A
1XBBA_STI
(SYK)
TK
Imatinib
I
31
170
75
31
170
75
A
1Y57A_MPZ
(SRC)
TK
MPZ
I
42
155
94
42
155
94
A
2GQGA_1N1
(ABL1)
TK
Dasatinib
I
74
32
117
74
32
117
A
3K54A_1N1
(BTK)
TK
Dasatinib
I
56
32
103
56
32
103
A
3OCTA_1N1
(BTK)
TK
Dasatinib
I
56
32
103
56
32
103
A
2C0TA_L3G
(HCK)
TK
A-641359
I
48
260
84
48
260
84
A
2H8HA_H8H
(SRC)
TK
Saracatinib
I
91
255
126
91
255
126
A
2WIHA_P48
(CDK2)
TK
VX_680
I
111
425
105
111
425
105
A
1M17A_AQ4
(EGFR)
TK
Erlotinib
I
43
166
82
43
166
82
A
1OI9A_N20
(CDK2)
TK
NU-6086
I
52
80
61
52
80
61
A
2VTTA_LZD
(CDK2)
TK
pyrazole dia...
I
158
42
111
158
42
111
A
2F4JA_VX6
(ABL1)
TK
VX-680
I
110
109
134
110
109
134
A
3C4CA_324
(BRAF)
TK
PLX4720
I
35
5
58
35
5
58
A
3C4DA_325
(BRAF)
TK
PLX4720
I
35
5
58
35
5
58
A
3OG7A_032
(BRAF)
TK
PLX4720
I
35
5
58
35
5
58
A
3PJ3A_04L
(BTK)
TK
Imatinib
II
99
113
134
99
113
134
A
3FQSA_585
(SYK)
TK
R-406
I
64
28
102
64
28
102
A
1OPLA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
3IKAA_0UN
(EGFR)
TK
2jkk
I
76
120
108
76
120
108
A
1AGWA_SU2
(FGFR1)
TK
SU 4984
I
77
81
111
77
81
111
A
2FO0A_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
3PIYA_585
(BTK)
TK
R-406
I
93
17
123
93
17
123
A
2G2HA_P16
(ABL1)
TK
PD166326
I
89
70
123
89
70
123
A
2HZIA_JIN
(ABL1)
TK
PD180970
I
90
77
120
90
77
120
A
2IW6A_QQ2
(CDK2)
TK
2iw6
I
112
209
86
112
209
86
B
33
2ITOA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
B
2ITOA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2ITUA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
2ITYA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
2ITWA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
2ITZA_IRE
(EGFR)
TK
Gefitinib
I
69
313
99
69
313
99
B
3BKBA_STU
(FES)
TK
staurosporine
I
131
107
138
131
107
138
B
3CBLA_STU
(FES)
TK
staurosporine
I
131
107
138
131
107
138
B
3CD3A_STU
(FES)
TK
staurosporine
I
131
107
138
131
107
138
B
3D7TA_STU
(CSK)
TK
staurosporine
I
70
68
99
70
68
99
B
3LCSA_STU
(ALK)
TK
staurosporine
I
73
100
109
73
100
109
B
2ITQA_STU
(EGFR)
TK
staurosporine
I
80
85
106
80
85
106
B
3LW0A_CCX
(IGF1R)
TK
5-vinyl-3-py...
III
53
30
101
53
30
101
B
2VWUA_7X1
(EPHB4)
TK
Chlorobenzod...
I
77
287
111
77
287
111
B
3MIYA_B49
(ITK)
TK
Sunitinib
I
70
74
110
70
74
110
B
3AOXA_EMH
(ALK)
TK
BIRB_796
I
34
28
85
34
28
85
B
2WKMA_PFY
(MET)
TK
PHA-665752
I
38
34
98
38
34
98
B
2R3KA_SCQ
(CDK2)
TK
2r3j
I
28
95
49
28
95
49
B
2R3LA_SCW
(CDK2)
TK
2r3j
I
19
63
41
19
63
41
B
3FQEA_P5C
(SYK)
TK
AMG_706
I
24
88
63
24
88
63
B
2C68A_CT6
(CDK2)
TK
2c68
I
23
73
43
23
73
43
B
2R3RA_6SC
(CDK2)
TK
2r3j
I
13
55
30
13
55
30
B
2X9FA_X9F
(EPHB4)
TK
X9F
I
46
19
86
46
19
86
B
2C69A_CT8
(CDK2)
TK
CT8
I
22
62
38
22
62
38
B
2R3FA_SC8
(CDK2)
TK
2c68
I
22
62
43
22
62
43
B
2R3GA_SC9
(CDK2)
TK
2r3j
I
30
137
50
30
137
50
B
1H00A_FAP
(CDK2)
TK
AC1NAE4F
I
50
94
75
50
94
75
B
2R3IA_SCF
(CDK2)
TK
2c68
I
23
89
43
23
89
43
B
2R3JA_SCJ
(CDK2)
TK
2r3j
I
27
99
49
27
99
49
B
3F5PA_741
(IGF1R)
TK
3-cyanoquino...
I
60
123
81
60
123
81
B
2XB7A_GUI
(ALK)
TK
NVP-TAE684
I
71
66
107
71
66
107
B
3EKNA_GS3
(INSR)
TK
pyrrolo[2,3-...
I
90
215
127
90
215
127
B
1H07A_MFP
(CDK2)
TK
AC1NAKJQ
I
90
241
80
90
241
80
B
3KCKA_3KC
(JAK2)
TK
L-779450
I
13
20
44
13
20
44
D
2
1R0PA_KSA
(MET)
TK
k-252a
I
28
79
64
D
1R0PA_KSA
(MET)
TK
k-252a
I
28
79
64
28
79
64
D
2WGJA_VGH
(MET)
TK
Crizotinib
I
21
23
55
21
23
55
E
24
2E2BA_406
(ABL1)
TK
Bafetinib
II
18
200
48
E
2E2BA_406
(ABL1)
TK
Bafetinib
II
18
200
48
18
200
48
E
2OO8X_RAJ
(TEK)
TK
RAJ
II
16
246
36
16
246
36
E
3BE2A_RAJ
(KDR)
TK
RAJ
II
19
249
47
19
249
47
E
1T46A_STI
(KIT)
TK
Imatinib
II
22
176
56
22
176
56
E
2HYYA_STI
(ABL1)
TK
Imatinib
II
16
182
52
16
182
52
E
3G0FA_B49
(KIT)
TK
Sunitinib
I
37
40
78
37
40
78
E
3G0EA_B49
(KIT)
TK
Sunitinib
I
37
40
78
37
40
78
E
2P2IA_608
(KDR)
TK
nicotinamide...
II
15
58
45
15
58
45
E
1UWHA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
3EFLA_706
(KDR)
TK
Motesanib
II
15
69
43
15
69
43
E
1UWJA_BAX
(BRAF)
TK
Sorafenib
II
19
39
35
19
39
35
E
3Q96A_0NF
(BRAF)
TK
(2s)-N-[3-(2...
II
19
21
35
19
21
35
E
3HNGA_8ST
(FLT1)
TK
HMS3229O07
II
10
91
21
10
91
21
E
3QRIA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
2OG8A_1N8
(LCK)
TK
1N8
II
35
190
69
35
190
69
E
3QRJA_919
(ABL1)
TK
Sorafenib
II
23
18
54
23
18
54
E
3EWHA_K11
(KDR)
TK
k11
II
17
27
46
17
27
46
E
1YWNA_LIF
(KDR)
TK
AC1NS1DP
II
17
49
42
17
49
42
E
2OFVA_242
(LCK)
TK
2ofv
II
28
181
65
28
181
65
E
2OSCA_MUH
(TEK)
TK
2osc
II
17
136
36
17
136
36
E
3CS9A_NIL
(ABL1)
TK
Nilotinib
II
19
132
48
19
132
48
E
3C1XA_CKK
(MET)
TK
AZD_1152HQPA
II
19
77
36
19
77
36
E
3LQ8A_88Z
(MET)
TK
AZD_1152HQPA
II
19
71
36
19
71
36
E
3C7QA_XIN
(KDR)
TK
BIBF1120
I
25
56
50
25
56
50
F
1
2RL5A_2RL
(KDR)
TK
Sorafenib
II
12
94
45
F
2RL5A_2RL
(KDR)
TK
Sorafenib
II
12
94
45
12
94
45